Medical equipment maker
Stereotaxis Inc.
(
STXS
) has reported adoption milestone for its Vdrive robotic navigation
system in Europe. The company said that the device is gaining
popularity in the continent and is expected to exceed 500 clinical
procedures in February 2012.
Vdrive enables surgeons to remotely manipulate traditionally
non-robotic catheters. According to Stereotaxis, since its initial
launch in Europe last year, the product has been deployed in nine
centers with more units slated to be installed in additional
centers during first-quarter 2012. The initial nine centers have
already performed 473 clinical procedures (mostly left atrial
surgeries) and have achieved positive clinical outcome.
The Vdrive system minimizes the need to re-enter the sterile
field to adjust devices in a fully remote procedure
environment. Initial clinical results from surgeons in Europe
showed that this simplification saves at least 30 minutes in
robotic procedures, depending on the individual clinical
technique.
Separately, Stereotaxis announced that the Vdrive system has
been cleared for marketing in Canada. With this approval and the
planned installations across Europe and Canada, the company is well
placed to drive further adoption of this innovative technology in
electrophysiology ("EP") labs in these key markets.
Missouri-based Stereotaxis develops and markets advanced
cardiology instrument control system for use in cardiac
catheterization labs for the treatment of coronary artery disease
and arrhythmias. The company's competitors include
Boston Scientific
(
BSX
) and
Edwards Lifesciences
(
EW
).
Stereotaxis offers the Niobe Magnetic Navigation System, which
allows physicians to perform complex interventional procedures.
Moreover, its Odyssey Enterprise Solution integrates and records
all lab data allowing physicians to focus on the patient for
optimal procedure efficiency.
The company, in December 2011, began shipment of its new Epoch
platform designed for the EP labs. Epoch is geared to improve
efficiency of cardiac procedures and increase workflow by enabling
physicians to control procedures remotely. The platform integrates
the benefits of remote magnetic catheter control, the efficiency of
remote robotic device manipulation and the Vdrive system, allowing
highly sophisticated procedural data integration and
transmission.
BOSTON SCIENTIF (
BSX
): Free Stock Analysis Report
EDWARDS LIFESCI (
EW
): Free Stock Analysis Report
STEREOTAXIS INC (
STXS
): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment
Research